IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v17y2000i4p351-360.html
   My bibliography  Save this article

Potential Savings in the Cost of Caring for Alzheimer’s Disease

Author

Listed:
  • A. Hauber
  • Ari Gnanasakthy
  • Edward Snyder
  • Mohan Bala
  • Anke Richter
  • Josephine Mauskopf

Abstract

Objective: To estimate savings in the cost of caring for patientswith Alzheimer’s disease (AD) during 6 months, 1 year and 2 years of treatment with rivastigmine. An intermediate objective was to estimate the relationship between disease progression and institutionalisation. Design and setting: We assessed the relationship between Mini-Mental State Examination (MMSE) score and institutionalisation using a piecewise Cox proportional hazard model. To estimate cost savings from treatments lasting 6 months, 1 year and 2 years, estimates of the probability of institutionalisation were integrated with data from two 6-month phase III clinical trials of rivastigmine and a hazard model of disease progression. Main outcome measures and results: Our data suggest that savings in the overall cost of caring for patients with mild and moderate AD can be as high as $US4839 per patient after 2 years of treatment. Furthermore, the probability of institutionalisation increases steadily as MMSE score falls. Among our study individuals, age, race, level of education and marital status were significant predictors of institutionalisation, whereas gender had little effect. Conclusions: Using rivastigmine to treat AD results in a delay in disease progression for patients who begin treatment during the mild or moderate stages of the disease. By delaying the probability that a patient will be institutionalised, the cost of caring for AD patients can be significantly reduced. Copyright Adis International Limited 2000

Suggested Citation

  • A. Hauber & Ari Gnanasakthy & Edward Snyder & Mohan Bala & Anke Richter & Josephine Mauskopf, 2000. "Potential Savings in the Cost of Caring for Alzheimer’s Disease," PharmacoEconomics, Springer, vol. 17(4), pages 351-360, April.
    • Handle: RePEc:spr:pharme:v:17:y:2000:i:4:p:351-360
    DOI: 10.2165/00019053-200017040-00005
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/00019053-200017040-00005
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.2165/00019053-200017040-00005?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jerrold Hill & Howard Fillit & Simu Thomas & Sobin Chang, 2006. "Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer’s Disease and Other Dementias," PharmacoEconomics, Springer, vol. 24(3), pages 265-280, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:17:y:2000:i:4:p:351-360. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.